DK0977562T3 - Fremgangsmåder og sammensætninger til indgivelse af taxaner - Google Patents

Fremgangsmåder og sammensætninger til indgivelse af taxaner

Info

Publication number: DK0977562T3
Authority: DK; Denmark
Prior art keywords: compositions; taxanes; methods; administration; taxol
Prior art date: 1998-03-10

Application number

DK99909941T

Other languages

Danish (da)

English (en)

Inventor

Lisa L Mcchesney-Harris

Original Assignee

Tapestry Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-10

Filing date

1999-03-10

Publication date

2006-05-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22138176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0977562(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-03-10 Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc

2006-05-01 Application granted granted Critical

2006-05-01 Publication of DK0977562T3 publication Critical patent/DK0977562T3/da

Links

239000000203 mixture Substances 0.000 title abstract 3
229940123237 Taxane Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
229930012538 Paclitaxel Natural products 0.000 abstract 2
229960001592 paclitaxel Drugs 0.000 abstract 2
AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
125000002456 taxol group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Dispersion Chemistry (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Epoxy Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK99909941T 1998-03-10 1999-03-10 Fremgangsmåder og sammensætninger til indgivelse af taxaner DK0977562T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7745998P	1998-03-10	1998-03-10

Publications (1)

Publication Number	Publication Date
DK0977562T3 true DK0977562T3 (da)	2006-05-01

Family

ID=22138176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99909941T DK0977562T3 (da)	1998-03-10	1999-03-10	Fremgangsmåder og sammensætninger til indgivelse af taxaner

Country Status (17)

Country	Link
US (1)	US20010029264A1 (de)
EP (1)	EP0977562B8 (de)
JP (1)	JP2001524988A (de)
KR (1)	KR20010012363A (de)
CN (1)	CN1255852A (de)
AT (1)	ATE314844T1 (de)
AU (1)	AU762926B2 (de)
BR (1)	BR9904856A (de)
CA (1)	CA2288240A1 (de)
CY (1)	CY1105690T1 (de)
DE (1)	DE69929313T2 (de)
DK (1)	DK0977562T3 (de)
ES (1)	ES2257038T3 (de)
IL (1)	IL131217A0 (de)
PT (1)	PT977562E (de)
WO (1)	WO1999045918A1 (de)
ZA (1)	ZA991885B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245805B1 (en) *	1995-10-26	2001-06-12	Baker Norton Pharmaceuticals, Inc.	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6964946B1 (en)	1995-10-26	2005-11-15	Baker Norton Pharmaceuticals, Inc.	Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6040330A (en) *	1999-01-08	2000-03-21	Bionumerik Pharmaceuticals, Inc.	Pharmaceutical formulations of taxanes
EP1479382A1 (de) *	1999-06-18	2004-11-24	IVAX Research, Inc.	Taxane enthaltende orale Pharmazeutische Zusammensetzungen sowie Behandlungsverfahren unter deren Verwendung
US6136846A (en)	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
US6828346B2 (en) *	1999-10-25	2004-12-07	Supergen, Inc.	Methods for administration of paclitaxel
WO2001052826A2 (en) *	2000-01-20	2001-07-26	Supratek Pharma Inc.	Novel podophyllotoxin compositions
CA2367661A1 (en) *	2000-02-02	2001-08-09	Robert A. Holton	Taxane formulations having improved solubility
US6919370B2 (en)	2000-11-28	2005-07-19	Transform Pharmaceuticals, Inc.	Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US7115565B2 (en)	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
CA2434641A1 (en) *	2001-01-18	2002-08-22	Pharmacia And Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US6710195B2 (en) *	2001-11-26	2004-03-23	Supergen, Inc.	Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
WO2003045357A1 (en) *	2001-11-27	2003-06-05	Transform Pharmaceuticals, Inc.	Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
GEP20063806B (en) *	2001-12-20	2006-04-25	Bristol Myers Squibb Co	Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
EP1480636B1 (de) *	2002-03-01	2007-04-18	Novagali Pharma SA	Selbstemulgierende systeme zur abgabe von taxoiden
EP1340497A1 (de) *	2002-03-01	2003-09-03	Novagali Sas	Selbstemulgierende Systeme zur Abgabe von schwerlöslichen Arzneimitteln
AR040693A1 (es) *	2002-07-30	2005-04-13	Wyeth Corp	Formulaciones parenterales
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
WO2004050068A1 (en)	2002-11-29	2004-06-17	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
US20040127551A1 (en) *	2002-12-27	2004-07-01	Kai Zhang	Taxane-based compositions and methods of use
AU2003300076C1 (en) *	2002-12-30	2010-03-04	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
WO2004091506A2 (en) *	2003-04-10	2004-10-28	Ivax Research, Inc.	Taxane-based compositions and methods of use
EP1498120A1 (de) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Halbfeste Formulierung für die orale Verabreichung des Taxols
EP1510206A1 (de) *	2003-08-29	2005-03-02	Novagali Pharma SA	Selbstnanoemulgierende ölige Formulierung zur Verabreichung wasserschwerlöslicher Wirkstoffe
CA2552925A1 (en) *	2004-01-30	2005-08-18	Pfizer Italia S.R.L.	Semisolid matrix pharmaceutical formulations
WO2005074889A1 (en) *	2004-02-03	2005-08-18	Dinesh Shantilal Patel	Novel compositions of taxol derivatives and the process for the manufacture thereof
US8003122B2 (en)	2004-03-31	2011-08-23	Cordis Corporation	Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7989490B2 (en) *	2004-06-02	2011-08-02	Cordis Corporation	Injectable formulations of taxanes for cad treatment
US7659310B2 (en)	2004-04-27	2010-02-09	Formatech, Inc.	Methods of enhancing solubility of agents
US7345093B2 (en)	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
EP1793806A2 (de) *	2004-09-30	2007-06-13	Eastman Chemical Company	Pharmazeutische formulierungen mit vitamin-e-molekülen zur solubilisierung von lipophilen arzneimitteln ohne signifikante ausflusshemmung und verwendung dieser formulierungen
US20070167422A1 (en) *	2006-01-18	2007-07-19	Yu Kwok S	Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
EP2271214B1 (de) *	2008-03-28	2017-05-03	Particle Sciences, Inc.	Pharmazeutische lösungen und verfahren zur auflösung von therapeutika
US8409601B2 (en)	2008-03-31	2013-04-02	Cordis Corporation	Rapamycin coated expandable devices
CN102000052B (zh) *	2008-06-25	2012-12-12	重庆市中药研究院	紫杉醇及其衍生物在制药中的应用
CA2781527C (en)	2009-09-23	2017-10-24	Indu Javeri	Methods for the preparation of liposomes
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
US20120065255A1 (en) *	2009-10-19	2012-03-15	Nagesh Palepu	Cabazitaxel formulations and methods of preparing thereof
US10842770B2 (en)	2010-05-03	2020-11-24	Teikoku Pharma Usa, Inc.	Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JP2014505054A (ja) *	2011-01-10	2014-02-27	セルジーンコーポレイション	シクロプロパンカルボン酸｛２−［（１ｓ）−１−（３−エトキシ−４−メトキシ−フェニル）−２−メタンスルホニル−エチル］−３−オキソ−２，３−ジヒドロ−１ｈ−イソインドール−４−イル｝−アミドの経口剤形
JO3685B1 (ar)	2012-10-01	2020-08-27	Teikoku Pharma Usa Inc	صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CA3026454C (en)	2015-06-04	2023-07-04	Crititech, Inc.	Collection device and methods for use
ES3055492T3 (en)	2015-09-16	2026-02-12	Dfb Soria Llc	Delivery of drug nanoparticles and methods of use thereof
EP3854381A1 (de)	2016-04-04	2021-07-28	Crititech, Inc.	Formulierungen zur behandlung von soliden tumoren
WO2018170196A1 (en)	2017-03-15	2018-09-20	Dfb Soria, Llc	Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
CA3063420A1 (en)	2017-06-09	2018-12-13	Crititech, Inc.	Treatment of epithelial cysts by intracystic injection of antineoplastic particles
WO2018231908A1 (en)	2017-06-14	2018-12-20	Crititech, Inc.	Methods for treating lung disorders
KR20250057947A (ko)	2017-10-03	2025-04-29	크리티테크, 인크.	암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
EP3765035A4 (de)	2018-03-16	2021-10-27	DFB Soria, LLC	Topische therapie zur behandlung von zervikalen intraepithelialen neoplasien (cin) und gebärmutterhalskrebs unter verwendung von taxannanopartikeln

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228162A (en) *	1979-07-09	1980-10-14	Research Corporation	Dimethyl isosorbide in liquid formulation of aspirin
US4578391A (en) *	1982-01-20	1986-03-25	Yamanouchi Pharmaceutical Co., Ltd.	Oily compositions of antitumor drugs
US4942184A (en) *	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
US4960790A (en) *	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
AU5612694A (en) *	1992-11-27	1994-06-22	Napro Biotherapeutics, Inc.	Injectable composition
DE59409377D1 (de) *	1993-10-22	2000-06-29	Hexal Ag	Pharmazeutische zusammensetzung mit cyclosporin a, einen vitamin e derivat und einen emulgator
US5877205A (en) *	1996-06-28	1999-03-02	Board Of Regents, The University Of Texas System	Parenteral paclitaxel in a stable non-toxic formulation
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs

1998
- 1998-03-10 IL IL13121798A patent/IL131217A0/xx unknown
1999
- 1999-03-09 ZA ZA9901885A patent/ZA991885B/xx unknown
- 1999-03-10 CA CA002288240A patent/CA2288240A1/en not_active Abandoned
- 1999-03-10 EP EP99909941A patent/EP0977562B8/de not_active Expired - Lifetime
- 1999-03-10 DE DE69929313T patent/DE69929313T2/de not_active Expired - Fee Related
- 1999-03-10 WO PCT/US1999/005151 patent/WO1999045918A1/en not_active Ceased
- 1999-03-10 BR BR9904856-6A patent/BR9904856A/pt not_active Application Discontinuation
- 1999-03-10 JP JP54602599A patent/JP2001524988A/ja not_active Ceased
- 1999-03-10 CN CN99800022A patent/CN1255852A/zh active Pending
- 1999-03-10 ES ES99909941T patent/ES2257038T3/es not_active Expired - Lifetime
- 1999-03-10 AU AU29022/99A patent/AU762926B2/en not_active Ceased
- 1999-03-10 KR KR19997010315A patent/KR20010012363A/ko not_active Withdrawn
- 1999-03-10 PT PT99909941T patent/PT977562E/pt unknown
- 1999-03-10 DK DK99909941T patent/DK0977562T3/da active
- 1999-03-10 AT AT99909941T patent/ATE314844T1/de not_active IP Right Cessation
2001
- 2001-02-28 US US09/795,626 patent/US20010029264A1/en not_active Abandoned
2006
- 2006-03-29 CY CY20061100438T patent/CY1105690T1/el unknown

Also Published As

Publication number	Publication date
DE69929313T2 (de)	2006-08-17
BR9904856A (pt)	2000-07-18
CN1255852A (zh)	2000-06-07
IL131217A0 (en)	2001-01-28
JP2001524988A (ja)	2001-12-04
WO1999045918A1 (en)	1999-09-16
ES2257038T3 (es)	2006-07-16
ATE314844T1 (de)	2006-02-15
AU2902299A (en)	1999-09-27
PT977562E (pt)	2006-05-31
EP0977562A1 (de)	2000-02-09
EP0977562B8 (de)	2006-04-26
EP0977562B1 (de)	2006-01-04
MX9910340A (en)	2000-04-01
CA2288240A1 (en)	1999-09-16
DE69929313D1 (de)	2006-03-30
ZA991885B (en)	1999-09-10
KR20010012363A (ko)	2001-02-15
US20010029264A1 (en)	2001-10-11
CY1105690T1 (el)	2010-12-22
AU762926B2 (en)	2003-07-10

Publication	Publication Date	Title
DK0977562T3 (da)	2006-05-01	Fremgangsmåder og sammensætninger til indgivelse af taxaner
DK1299348T3 (da)	2008-07-28	Forbindelser og sammensætninger til levering af aktive midler
DK0762896T3 (da)	2003-01-06	Tocopherol-sammensætninger til levering af biologisk aktive stoffer
DK0993831T3 (da)	2008-03-25	Forbindelser og præparater til tilförsel af aktive stoffer
ATE472551T1 (de)	2010-07-15	Tocopherolmodifizierte therapeutische arzneimittelverbindung
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200101481T2 (tr)	2001-09-21	Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DE69729786D1 (de)	2004-08-12	Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE69910230D1 (de)	2003-09-11	Paclitaxel enthaltende arzneimittel
DK1098649T3 (da)	2004-10-04	Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant
EP1100522A4 (de)	2003-01-08	Verabreichung aktiver wirkstoffe über die lunge
ES2184149T3 (es)	2003-04-01	Paclitaxeles 6-tio sustituidos.
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
DK0758231T3 (da)	2001-09-24	Farmaceutiske præparater på basis af derivater tilhørende taxanklassen
MXPA03007857A (es)	2004-05-24	Compuestos y composiciones para entregar agentes activos.
ATE311373T1 (de)	2005-12-15	Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
CY1105225T1 (el)	2010-03-03	Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
TR199801861T2 (xx)	1998-12-21	Farmas�tik olarak yararl� bile�imler.
DE60209929D1 (de)	2006-05-11	Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
SE0102843L (sv)	2001-10-26	Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
EA200301023A1 (ru)	2004-02-26	Заместительная терапия эстрогенами
WO2002078690A3 (en)	2002-11-21	Taxoid anti-tumor agents and pharmaceutical compositions thereof
TR200302134T4 (tr)	2004-01-21	2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE60217315D1 (de)	2007-02-15	Pharmazeutische zusammensetzungen von rapamycines
WO2001037780A8 (en)	2001-11-08	Urotensin-ii analogs